DMEPOS Temporary COVID-19 Guidelines
Alaska Medicaid has implemented temporary COVID-19 guidelines that effect DME and P&O providers. Access current DMEPOS temporary guidelines here. Providers may also review all Alaska Medicaid program announcements regarding COVID-19 on the Health Enterprise Home Page.
DME Quarterly Update Teleconference April 2020
Thank you to all of the providers that attended our quarterly DME teleconference! The April 2020 presentation is available under Quarterly Teleconference Presentations. Our next meeting is projected for July 7, 2020 at 10:00 a.m. AKST.
Alaska Medicaid DMEPOS FAQs
Q1: If we dispense a 90-day supply, will my claim auto-deny for excess quantity?
A1: No. These claims are suspended and reviewed by the State for reimbursement.
Q2: Do I have to submit documentation that the recipient agreed to a 90-day supply?
A2: No. However, this documentation should be on file with provider.
Q3: I have some enteral SAs that are expiring in between the timeframes listed on the temporary guidelines, what do I do?
A3: Follow the directions within the DMEPOS Temporary Guidelines During COVID-19 Outbreak. If you still have specific concerns, email the State for individual assistance on those SAs.
Q4: Are all RAD devices, including CPAPs and BiPAPs, included in the ventilator and oxygen section of the guidelines?
A4: No. Due to the extensive qualification requirements, we are developing additional guidelines specific to these devices.
Q5: Will Alaska Medicaid allow a new wheelchair evaluation to be performed through telemedicine?
A5: Not at this time. We are reviewing this area of the program and will provide further guidance as applicable.